Gamcemetinib clinical trials
Also written CC-99677.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How each study uses gamcemetinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
7 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Protein Kinase Inhibitors source
Studies
Open first, then newest update. How each study uses gamcemetinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- A Study of CC-99677 in Participants With Active Ankylosing SpondylitisTerminatedPhase 2CelgeneNCT04947579Written as CC-99677
- A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of SulfasalazineCompletedPhase 1Bristol-Myers SquibbNCT05445440Written as BMS-986371
- A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT05284890Written as CC-99677
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-99677 in Healthy Adult Japanese Participants.CompletedPhase 1CelgeneNCT04958291Written as CC-99677
- A Study to Evaluate Effects of CC-99677 on the Pharmacokinetics of an Oral Contraceptive in Healthy Female ParticipantsCompletedPhase 1CelgeneNCT04718636Written as CC-99677
- A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677CompletedPhase 1CelgeneNCT04268394Written as CC-99677
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of CC-99677 in Healthy Adult SubjectsCompletedPhase 1CelgeneNCT03554993Written as CC-99677
Codes
What other systems call gamcemetinib · ClinicalTrials.gg INT017496
- UNII (FDA) OS2IR8TV1OGAMCEMETINIBOne source FDA
- NCI Thesaurus C199205GamcemetinibOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | OS2IR8TV1O | GAMCEMETINIB | One source FDA |
| NCI Thesaurus | C199205 | Gamcemetinib | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.